NCT00296946View on ClinicalTrials.gov

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

June 30, 2006

Conditions
Parkinson's Disease
Interventions
DRUG

ipratropium bromide (drug)

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, University Health Network, Toronto

All Listed Sponsors
collaborator

Parkinson's Disease Foundation

OTHER

lead

University Health Network, Toronto

OTHER

NCT00296946 - Ipratropium Spray for Drooling Saliva in Parkinson's Disease | Biotech Hunter | Biotech Hunter